Skip to content

Cannabis research published in 2012

Page 2 of 3: studies 21 to 40 of 52, newest first. Back to the cannabis overview

Studies

Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users.

Psychopharmacology August 2012 Joanna Jacobus, Diane Goldenberg, Christina E Wierenga et al.

The effects of adolescent marijuana use on the developing brain remain unclear, despite its prevalence. Arterial spin labeling (ASL) is a noninvasive imaging technique that characterizes neurovascular status and cerebral blood flow (CBF), potentially revealing contributors to neuropathological alterations. No studies to date have looked at CBF in adolescent marijuana users. This study examined...

Alterations of theory of mind network activation in chronic cannabis users.

Schizophrenia Research August 2012 Patrik Roser, Silke Lissek, Martin Tegenthoff et al.

Chronic cannabis use is associated with cognitive impairment and has been identified as a risk factor for schizophrenia. Patients with schizophrenia show profound deficits in social cognition such as the ability to attribute mental states to others, referred to as "theory of mind" (ToM). Aberrant activation of the ToM network has been demonstrated across different phases of schizophrenia,...

A prospective study of learning, memory, and executive function in new MDMA users

Addiction July 26, 2012 Daniel Wagner, Benjamin Becker, Philip Koester et al. 54 citations

Abstract Aims It is still unclear if cognitive abnormalities in human 3,4‐methylenedioxymeth‐amphetamine ( MDMA ) users existed before the beginning of use or if other confounders could explain the deficits. The present study was conducted in order to assess the relationship between beginning MDMA use and subsequent cognitive performance and to overcome previous methodological shortcomings....

Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.

British Journal of Clinical Pharmacology July 2012 Linda E. Klumpers, Tim L Beumer, Johan G C Van Hasselt et al.

• Cannabis based medicines are registered as a treatment for various indications, such as pain and spasms in multiple sclerosis (MS) patients, and anorexia and nausea in patients with HIV or receiving cancer treatment. • the pharmacokinetics of the various administration routes of cannabis and cannabis based medicines are variable and dosing is hard to regulate. • Namisol is a new tablet...

Neural Correlates of the Severity of Cocaine, Heroin, Alcohol, MDMA and Cannabis Use in Polysubstance Abusers: A Resting-PET Brain Metabolism Study

PLoS One June 29, 2012 Laura Moreno-López, Emmanuel A. Stamatakis, María José Fernández-serrano et al. 73 citations

INTRODUCTION: Functional imaging studies of addiction following protracted abstinence have not been systematically conducted to look at the associations between severity of use of different drugs and brain dysfunction. Findings from such studies may be relevant to implement specific interventions for treatment. The aim of this study was to examine the association between resting-state regional...

Mitigation of post‐traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence

Drug Testing and Analysis June 26, 2012 Torsten Passie, Hinderk M. Emrich, Matthias Karst et al. 114 citations

It is known from clinical studies that some patients attempt to cope with the symptoms of post-traumatic stress disorder (PTSD) by using recreational drugs. This review presents a case report of a 19-year-old male patient with a spectrum of severe PTSD symptoms, such as intense flashbacks, panic attacks, and self-mutilation, who discovered that some of his major symptoms were dramatically...

Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans.

Neuropsychopharmacology June 2012 Deepak Cyril D'Souza, Daniel J Fridberg, Patrick D. Skosnik et al.

Cannabinoids induce a host of perceptual alterations and cognitive deficits in humans. However, the neural correlates of these deficits have remained elusive. The current study examined the acute, dose-related effects of delta-9-tetrahydrocannabinol (Δ⁹-THC) on psychophysiological indices of information processing in humans. Healthy subjects (n=26) completed three test days during which they...

Substance use initiation: The role of simultaneous polysubstance use

Drug and Alcohol Review May 21, 2012 Janine V. Olthuis, Christine Darredeau, Sean P. Barrett 79 citations

Abstract Introduction and Aims. Simultaneous polysubstance use (SPU) is a common phenomenon, yet little is known about its role in substance use initiation. Design and Methods. In the present study, 226 cannabis users completed structured interviews about their substance use history. For each substance ever used, participants provided details of their age of first use, their use in the...

Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images

Journal of Psychopharmacology May 13, 2012 Michael E. Ballard, Gillinder Bedi, Harriet de Wit 52 citations

There is growing evidence that drugs of abuse alter processing of emotional information in ways that could be attractive to users. Our recent report that Δ⁹-tetrahydrocannabinol (THC) diminishes amygdalar activation in response to threat-related faces suggests that THC may modify evaluation of emotionally-salient, particularly negative or threatening, stimuli. In this study, we examined the...

DOI: 10.1177/0269881112446530 (opens in new tab) Sadness Anger Happiness Affect linguistics +9

Delay- and dose-dependent effects of Δ⁹-tetrahydrocannabinol administration on spatial and object working memory tasks in adolescent rhesus monkeys.

Neuropsychopharmacology May 2012 Christopher D. Verrico, Shijing Liu, Elizabeth J Bitler et al.

Among adolescents, the perception that cannabis can cause harm has decreased and use has increased. However, in rodents, cannabinoid administration during adolescence induces working memory (WM) deficits that are more severe than if the same exposure occurs during adulthood. As both object and spatial WM mature in a protracted manner, although apparently along different trajectories, adolescent...

Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study.

Biological Psychiatry April 15, 2012 Nina B L Urban, Mark Slifstein, Judy L. Thompson et al.

Low striatal dopamine 2/3 receptor (D(2/3)) availability and low ventrostriatal dopamine (DA) release have been observed in alcoholism and cocaine and heroin dependence. Less is known about the dopaminergic system in cannabis dependence. We assessed D(2/3) availability and DA release in abstinent cannabis users compared with control subjects and explored relationships to cannabis use history...

Separate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC.

Drug and Alcohol Dependence April 1, 2012 Joshua A Lile, Thomas H Kelly, Lon R Hays

The involvement of non-cannabinoid neurotransmitter systems in the abuse-related behavioral effects of cannabis has not been well characterized in humans. GABAergic drugs have overlapping effects with cannabis and Δ(9)-tetrahydrocannabinol (Δ(9)-THC) on certain behavioral measures, but those measures lack the specificity to draw conclusions regarding the involvement of GABA in cannabinoid...

Combined effects of THC and caffeine on working memory in rats.

British Journal of Pharmacology April 2012 Leigh V Panlilio, Sergi Ferré, Sevil Yasar et al.

Cannabis and caffeine are two of the most widely used psychoactive substances. Δ(9) -Tetrahydrocannabinol (THC), the main psychoactive constituent of cannabis, induces deficits in short-term memory. Caffeine, a non-selective adenosine receptor antagonist, attenuates some memory deficits, but there have been few studies addressing the effects of caffeine and THC in combination. Here, we evaluate...

Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.

Psychological Medicine April 2012 J H Meijer, N Dekker, M W Koeter et al.

The relationship between cannabis use and cognitive functioning in patients with psychosis has yielded contradictory findings. In individuals at genetic high risk for psychosis, information is sparse. The aim of this study was to assess the association between recency and frequency of cannabis use and cognitive functioning in patients with psychosis and their unaffected siblings. We conducted a...

Cannabis‐related deficits in real‐world memory

Human Psychopharmacology: Clinical and Experimental March 1, 2012 Catharine Montgomery, Alexandra L. Seddon, John E. Fisk et al. 56 citations

BACKGROUND: Research shows that cannabis users exhibit deficits in prospective memory (PM) and executive function, which persist beyond acute intoxication. However, many studies rely on self-reports of memory failures or use laboratory-based measures that may not mimic functional deficits in the real world. The present study aimed to assess real-world memory functioning. METHOD: Twenty...

The effects of multitasking on psychological stress reactivity in recreational users of cannabis and MDMA

Human Psychopharmacology: Clinical and Experimental March 1, 2012 Mark Wetherell, Katie Atherton, Jessica Grainger et al. 25 citations

Background Cannabis and 3,4‐methylenedioxymethamphetamine (MDMA) use is associated with psychobiological and neurocognitive deficits. Assessments of the latter typically include tests of memory and everyday cognitive functioning. However, to date, little attention has been paid to effects of drug use on psychological stress reactivity. We report three studies examining the effects of...

DOI: 10.1002/hup.1261 (opens in new tab) MDMA Human multitasking Stressor Neurocognitive +4

Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines.

Journal of Medical Toxicology March 1, 2012 Christopher D Rosenbaum, Stephanie P Carreiro, Kavita M. Babu 356 citations

Despite their widespread Internet availability and use, many of the new drugs of abuse remain unfamiliar to health care providers. The herbal marijuana alternatives, like K2 or Spice, are a group of herbal blends that contain a mixture of plant matter in addition to chemical grade synthetic cannabinoids. The synthetic cathinones, commonly called "bath salts," have resulted in nationwide...

DOI: 10.1007/s13181-011-0202-2 (opens in new tab) Full text (opens in new tab) Salvia divinorum New psychoactive substances Nps Novel psychoactive substances +36

Effects of chronic marijuana use on brain activity during monetary decision-making.

Neuropsychopharmacology February 2012 Jatin G Vaidya, Robert I Block, Daniel S O'Leary et al.

Marijuana (MJ) acutely acts on cannabinoid receptors that are found in numerous brain regions, including those involved in reward processing and decision-making. However, it remains unclear how long-term, chronic MJ use alters reward-based decision-making. In the present study, using [(15)O]water PET imaging, we measured brain activity in chronic MJ users, who underwent monitored abstinence...

Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being

Psychological Medicine February 1, 2012 C. J. A. Morgan, Chelsea Gardener, G. Schafer et al.

Background Cannabis varies considerably in levels of its two major constituent cannabinoids – (delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Recently, we found evidence that those who smoked cannabis containing detectable levels of CBD had fewer psychotic-like symptoms than those whose cannabis had no CBD. The present study aimed, first, to replicate those findings and, second, to...

Involvement of opioid system in cognitive deficits induced by ∆⁹-tetrahydrocannabinol in rats.

Psychopharmacology February 2012 Nobuaki Egashira, Naomi Manome, Kenichi Mishima et al.

Cannabis is a widely used illicit substance. ∆(9)-Tetrahydrocannabinol (THC), the major psychoactive component of cannabis, is known to induce cognitive deficits that closely resemble the impairment observed in schizophrenic patients. We previously reported that THC (6 mg/kg) impairs spatial memory in the eight-arm radial maze, and that this memory disturbance was reversed by the cannabinoid...